approval
saveVANRAFIA (ATRASENTAN HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvallutetium Lu 177 vipivotide tetraxetan: PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvalMar 28, 2025
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025
- approvallutetium Lu 177 vipivotide tetraxetan: PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvalMar 28, 2025
- approvalSpexotras: MEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalApr 7, 2025
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalApr 7, 2025
comments(0)
5-min edit window · permanent after that